Implementing the Chinese mandatory antimicrobial stewardship program: barriers to continuous improvement
This study aims to investigate the implementation strategy, unintended consequences, and underlying barriers to mandatory antimicrobial stewardship (AMS) programs in China. Face-to-face, in-depth qualitative interviews were conducted in 16 public hospitals in eastern, central, and western China. Hospitals were purposely selected with full consideration to represent both economically developing and developed areas and both secondary and tertiary care hospitals. A total of 111 respondents were interviewed, including 38 doctors, 28 clinical pharmacists, 15 microbiologists, 14 infection prevention and control specialists, 10 experts from medical service departments, and 6 quality improvement experts. A thematic framework analysis was conducted. A common implementation strategy was found among the surveyed hospitals in response to the AMS programs mandated by healthcare authorities. The hospital leadership empowered an AMS team to set AMS-related indicators for each clinical department and each doctor, and adopted core elements of AMS to optimize antimicrobial prescribing. However, the mandatory AMS approach also caused unintended consequences including regulatory circumvention, shift of risk to doctors and patients, and demotivation of healthcare workers. Two key barriers to AMS implementation were identified: (i) poor communication and cooperation between the AMS team and doctors, characterized by a high-power-low-power dynamic within hospital disciplines; and (ii) the profit-driven compensation system, which discourages collaboration and resource distribution for AMS implementation. Mandatory AMS programs should intensify AMS training, promote communication and cooperation between the AMS team and doctors, adjust the compensation system to facilitate better AMS implementation, and offer supportive measures that enable the adoption of strict regulations.
Authors
- Laith Yakob (ORCID: https://orcid.org/0000-0001-8639-4511)
- Xudong Zhou (ORCID: https://orcid.org/0000-0002-0784-5343)
- Stephan Harbarth (ORCID: https://orcid.org/0000-0002-3551-1025)
- R. Zhang (ORCID: https://orcid.org/0000-0001-5623-5229)
- Leesa Lin (ORCID: https://orcid.org/0000-0003-4123-4762)
- Xiaomin Wang (ORCID: https://orcid.org/0000-0003-1318-2432)
- Xin Xu (ORCID: https://orcid.org/0009-0002-2360-9575)
Institutions
- University of Geneva (CH)
- University of London (GB)
- Emory University (US)
- Hangzhou Normal University (CN)
- Hong Kong Science and Technology Parks Corporation (HK)
- London School of Hygiene & Tropical Medicine (GB)
- Second Affiliated Hospital of Zhejiang University (CN)
- Geneva College (US)
- Zhejiang University (CN)
- University of Hong Kong (HK)
Publication Details
- Journal
- Health Policy and Planning
- Published
- 2025-03-20
- DOI
- https://doi.org/10.1093/heapol/czaf019
- Citations
- 1
- Primary Topic
- Antibiotic Use and Resistance
- Type
- article
- Field-Weighted Citation Impact
- 1.26
Funders
- China Medical Board
- National Natural Science Foundation of China